Zhao Zhi-hong, Shan Jiang, Xiang Mei-xiang, Xu Geng, Fu Guo-sheng, Bao Xiao-feng
The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310009, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 Sep;34(5):447-53, 464. doi: 10.3785/j.issn.1008-9292.2005.05.014.
To investigate the effect of long-term administration of fluvastatin on improvement of ventricular remodeling of rats after myocardial infarction and its mechanism.
Sprague-Dawley rats were subjected to ligation in anterior descending branch of coronary artery and treated with fluvastatin (20 mg.kg(-1) d(-1)) or distilled water for 8 weeks. Doppler echocardiography, hemodynamic study and cardiac histomorphometry were used to estimate the ventricular remodeling and cardiac function. Laser scanning confocal microscope was used to definite the distribution of superoxide anion (O(2)(*-)) and nitrogen monoxide. RT-PCR and immunohistochemistry were used to detect the expression of NOS2 and p22phox in mRNA and protein level. The level of lipid peroxidation, glutathione peroxidase, nitrogen monoxide and total cholesterol were detected too.
Administration of fluvastatin ameliorated left ventricular remodeling without affecting the infarct size [(40 +/- 6 vs 42 +/-5)%, P>0.05]. The level of left ventricular end-diastolic pressure [(18.24 +/-6.58 vs 10.74 +/-4.71) mmHg, P<0.05], right ventricular ameliorated relative weight [(0.92 +/-0.19 vs 0.71 +/-0.13) g/kg, P<0.05], the thickness of left ventricular posterior wall [(3.04 +/-0.28 vs 2.60 +/-0.36) mm, P<0.05] decreased after fluvastatin treatment. The left ventricular ejection fraction was not influenced, the relative lung weight and the left atrium diameter reduced [(5.79 +/-2.92 vs 3.69 +/-0.68) g/kg, (0.55 +/-0.12 vs 0.45 +/-0.04) mm, P<0.05]; the expressions of LPO in the plasma and myocardium [(8.64 +/-0.59 vs 7.71 +/-0.66) U/dl, P<0.05; (3.12 +/-0.38 vs 1.93 +/-0.40) ng/microg.pro, P<0.01] were reduced, and the overexpressed NO was inhibited [(436.87 +/-47.22 vs 313.78 +/-34.35) mg/dl, P<0.01], but the expression of GPx increased [(66.13 +/-8.31 vs 79.78 +/-2.38) mg/dl, P<0.01]. The expression of O(2)(*-) and the activity of NADPH oxidase subunit p22phox increased; NOS2 and its products NO were over-expressed too.
Ventricular remodeling and hemodynamics are improved profoundly in MI rats treated with fluvastatin. The effect of antioxidative stress of fluvastatin might be involved in the mechanism.
探讨长期给予氟伐他汀对心肌梗死后大鼠心室重构的改善作用及其机制。
将Sprague-Dawley大鼠冠状动脉前降支结扎,用氟伐他汀(20mg·kg⁻¹·d⁻¹)或蒸馏水治疗8周。采用多普勒超声心动图、血流动力学研究和心脏组织形态计量学评估心室重构和心脏功能。用激光扫描共聚焦显微镜确定超氧阴离子(O₂⁻·)和一氧化氮的分布。采用RT-PCR和免疫组织化学检测NOS2和p22phox在mRNA和蛋白水平的表达。同时检测脂质过氧化水平、谷胱甘肽过氧化物酶、一氧化氮和总胆固醇水平。
给予氟伐他汀改善了左心室重构,但不影响梗死面积[(40±6 vs 42±5)%,P>0.05]。氟伐他汀治疗后左心室舒张末期压力水平[(18.24±6.58 vs 10.74±4.71)mmHg,P<0.05]、右心室相对重量改善[(0.92±0.19 vs 0.71±0.13)g/kg,P<0.05]、左心室后壁厚度[(3.04±0.28 vs 2.60±0.36)mm,P<0.05]降低。左心室射血分数未受影响,相对肺重量和左心房直径减小[(5.79±2.92 vs 3.69±0.68)g/kg,(0.55±0.12 vs 0.45±0.04)mm,P<0.05];血浆和心肌中LPO的表达[(8.64±0.59 vs 7.71±0.66)U/dl,P<0.05;(3.12±0.38 vs 1.93±0.40)ng/μg·pro,P<0.01]降低,过表达的NO受到抑制[(436.87±47.22 vs 313.78±34.35)mg/dl,P<0.01],但GPx的表达增加[(66.13±8.31 vs 79.78±2.38)mg/dl,P<0.01]。O₂⁻·的表达和NADPH氧化酶亚基p22phox的活性增加;NOS2及其产物NO也过表达。
氟伐他汀治疗的心肌梗死大鼠心室重构和血流动力学得到显著改善。氟伐他汀的抗氧化应激作用可能参与其机制。